The present study provides evidence that in an experimental model of severe obesity, LECS reduced blood glucose and insulin levels, improved glucose tolerance and insulin sensitivity, and increased activity of hepatic transaminases without modification of body weight and food intake. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.